arrow
L

Lisa M. DeAngelis

Memorial Sloan Kettering Cancer Center
H指数:112
被引数:4.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CERN 09-02: A Phase 2 Trial of Carboplatin and Bevacizumab for Recurrent Adult Ependymomas

CERN 09-02:卡铂和贝伐珠单抗治疗复发成人室管膜瘤的二期临床试验

2026-03-090
OA
Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine for newly diagnosed primary CNS lymphoma

伊布替尼联合利妥昔单抗、甲氨蝶呤、长春新碱和丙卡巴肼治疗新诊断的原发性中枢神经系统淋巴瘤

2026-03-010
PRE
PHASE IB STUDY OF COPANLISIB, A PAN PI3K INHIBITOR, IN COMBINATION WITH IBRUTINIB, A BTK INHIBITOR, IN RELAPSED OR REFRACTORY PRIMARY CNS LYMPHOMA

I期B研究:评估泛PI3K抑制剂copanlisib与BTK抑制剂ibrutinib联合治疗复发或难治性原发性中枢神经系统淋巴瘤的疗效。

2025-11-010
OAAI
CERN 09-02: A PHASE 2 TRIAL OF CARBOPLATIN AND BEVACIZUMAB FOR RECURRENT ADULT EPENDYMOMA

CERN 09-02:一项关于卡铂和贝伐珠单抗治疗复发性成人室管膜瘤的II期临床试验

2025-11-010
OAAI
MULTICENTER RANDOMIZED PHASE II STUDY OF R-MPV-A CHEMOIMMUNOTHERAPY WITH OR WITHOUT LOW-DOSE WHOLE-BRAIN RADIOTHERAPY FOR NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: NRG/ RTOG 1114

多中心随机II期研究:R-MPV-A化疗免疫疗法联合或单用低剂量全脑放射治疗新诊断的原发性中枢神经系统淋巴瘤:NRG/RTOG 1114

2025-10-010
OA
Multicenter basket trial for central nervous system tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningioma

多中心篮式试验针对中枢神经系统肿瘤,确定了CDK4/6抑制剂abemaciclib在复发性脑膜瘤中的活性

2025-10-010
PRE
Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma

Omuro, A.; DeAngelis, L.M.; Polley, M.C.; Correa, D.; Wefel, J.S.; Bovi, J.A.; Rosenblum, M.; Corn, B.W.; Aneja, S.; Grommes, C.; et al. 多中心随机II期研究:R-MPV-A化疗免疫疗法联合或不联合低剂量全脑放疗治疗新诊断的原发性中枢神经系统淋巴瘤。Neuro Oncol. 2025, noaf221. [Google Scholar] [CrossRef]

2025-10-010
PRE
Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors

胶质瘤和神经胶质神经元肿瘤患者胚系变异的前瞻性表征

2025-09-120
OAAI
Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma

Ib期研究:在复发/难治性中枢神经系统淋巴瘤患者中扩大伊布替尼、来那度胺和利妥昔单抗的应用

2025-06-010
PRE
PROSPECTIVE GERMLINE SEQUENCING OF PATIENTS WITH GLIOMAS, GLIONEURONAL OR NEURONAL TUMORS
2024-11-110
PRE
Advancing Global Health Equity in Oncology Clinical Trial Access
2024-09-240
PRE